Vident Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,104
| Closed | -$762K | – | 1448 |
|
|
2024
Q2 | $762K | Buy |
14,104
+61
| +0.4% | +$3.29K | 0.02% | 698 |
|
|
2024
Q1 | $957K | Buy |
14,043
+3,561
| +34% | +$243K | 0.02% | 586 |
|
|
2023
Q4 | $656K | Buy |
10,482
+357
| +4% | +$22.3K | 0.02% | 684 |
|
|
2023
Q3 | $460K | Buy |
+10,125
| New | +$460K | 0.01% | 730 |
|